Want to see DE:GME full AI Analyst Report?
GME Stock Chart & Stats
€2.86
-€0.08(-2.22%)
At close: 4:00 PM EST
€2.86
-€0.08(-2.22%)
Day’s Range― - ―
52-Week Range€2.39 - €7.88
Previous CloseN/A
Volume28.00
Average Volume (3M)216.00
Market Cap
€13.34M
Enterprise Value€7.55
Total Cash (Recent Filing)€8.81M
Total Debt (Recent Filing)€2.19M
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Apr 27, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.08%
Share Statistics
EPS (TTM)-0.14
Shares Outstanding5,444,998
10 Day Avg. Volume315
30 Day Avg. Volume216
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)0.80
Price to Sales (P/S)1.05
P/FCF Ratio12.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)€15.00M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a substantial equity base provide financial flexibility for a medical-device business. This structure reduces balance-sheet pressure, supports resilience during uneven operating periods, and preserves capacity to fund products, distribution, or other strategic priorities.
Positive Cash GenerationPositive operating and free cash flow indicate that Geratherm is still converting its activities into cash despite recent earnings weakness. Continued cash generation can help support operations and investment internally, reducing reliance on additional borrowing or external capital.
Strong Gross MarginA gross margin near 67% provides meaningful economic value before operating costs and suggests the product portfolio can retain substantial value from each sale. Combined with healthcare and retail distribution, this supports a scalable commercial model if volumes stabilize.
Bears Say
Return To LossesThe return to net and operating losses weakens the durability of current earnings and reduces internal funding capacity. Even with a strong gross margin, negative EBIT shows that operating expenses currently absorb more than the business generates, requiring a sustained recovery in execution.
Volatile Revenue PerformanceSharp and volatile revenue performance makes it harder to plan production, distribution, and investment with confidence. Persistent weakness in the top line can dilute fixed-cost absorption, pressure operating margins, and limit the company’s ability to convert its medical-device presence into durable growth.
Weakening Free Cash FlowAlthough free cash flow remains positive, its substantial decline reduces confidence in the strength and repeatability of cash generation. Weaker cash conversion leaves less capacity for product development, channel expansion, dividends, or other investments without drawing on existing financial resources.
GME FAQ
What was Geratherm Medical AG’s price range in the past 12 months?
Geratherm Medical AG lowest stock price was €2.39 and its highest was €7.88 in the past 12 months.
What is Geratherm Medical AG’s market cap?
Geratherm Medical AG’s market cap is €13.34M.
When is Geratherm Medical AG’s upcoming earnings report date?
Geratherm Medical AG’s upcoming earnings report date is Apr 27, 2027 which is in 218 days.
How were Geratherm Medical AG’s earnings last quarter?
Geratherm Medical AG released its earnings results on Aug 27, 2026. The company reported -€0.08 earnings per share for the quarter.
Is Geratherm Medical AG overvalued?
According to Wall Street analysts Geratherm Medical AG’s price is currently Overvalued.
Does Geratherm Medical AG pay dividends?
Geratherm Medical AG pays a Annually dividend of €0.1 which represents an annual dividend yield of 4.08%. See more information on Geratherm Medical AG dividends here
What is Geratherm Medical AG’s EPS estimate?
Geratherm Medical AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Geratherm Medical AG have?
Geratherm Medical AG has 5,444,998 shares outstanding.
What happened to Geratherm Medical AG’s price movement after its last earnings report?
Geratherm Medical AG reported an EPS of -€0.08 in its last earnings report. Following the earnings report the stock price went up 0.806%.
Which hedge fund is a major shareholder of Geratherm Medical AG?
Currently, no hedge funds are holding shares in DE:GME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Geratherm Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.12%
12-Months-Change
Fundamentals
Return on Equity
4.08%
Trailing 12-Months
Asset Growth
-7.22%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Geratherm Medical AG
Geratherm Medical AG, a German-based medical technology enterprise, organizes its operations across four primary divisions: Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems. The Healthcare Diagnostic unit offers a range of items including clinical thermometers, blood pressure monitors, and various self-test diagnostic products designed for women, such as pregnancy tests, chlamydia screens, urinary tract infection indicators, diverse ovulation solutions, and pH tests. Its Respiratory segment is dedicated to the development and production of equipment primarily for diagnosing pulmonary and cardiopulmonary function. Under the LMT brand, the Medical Warming Systems division manufactures MRI-compatible incubators for premature and newborn infants. The Cardio/Stroke segment provides analytical products aimed at assessing stroke risk by detecting atrial fibrillation. The company markets its healthcare solutions via pharmacies, hospitals, and clinics, and successfully exports its merchandise to approximately 60 nations worldwide. Established in 1990, Geratherm Medical AG's headquarters are situated in Geschwenda, Germany.
Technical Analysis
Draegerwerk AG & Co. KGaA
―
MeVis Medical Solutions
―
STRATEC Biomedical
―
Siemens Healthineers AG
―
elexxion AG
―